Simplex Trading, LLC Alzamend Neuro, Inc. Transaction History

Simplex Trading, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	SELL	$0.19 - $0.52 $76 - $208	-400 Reduced 83.51%	79 $0
Q2 2023 Aug 04, 2023	BUY	$0.49 - $0.77 $234 - $368	479 New	479 $0
Q2 2022 Aug 03, 2022	SELL	$0.82 - $1.2 $26,227 - $38,382	-31,985 Reduced 92.21%	2,701 $2,000
Q1 2022 May 02, 2022	SELL	$0.91 - $2.23 $28,336 - $69,439	-31,139 Reduced 47.31%	34,686 $42,000
Q4 2021 Feb 23, 2022	BUY	$1.9 - $3.08 $125,067 - $202,741	65,825 New	65,825 $125,000

Ticker ALZN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,481,800
Market Cap $115M
Description
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001 that is in Phase II clinical trial, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.